PAREXEL International appoints Simon Harford as Senior Vice President and Chief Financial Officer

Appointment Effective June 1, 2017

ID: 1490135
recent pressrelease next pressrelease

(businesspress24) - LONDON, February 28, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of Simon Harford as Senior Vice President and Chief Financial Officer effective June 1, 2017. He will serve on PAREXEL''s Business Review Committee, the Company''s senior-most leadership team, and assist in developing and implementing PAREXEL''s strategic objectives. Mr. Harford will be based at the Company’s corporate headquarters in Waltham, Massachusetts.

“Simon brings to PAREXEL more than three decades of global financial management and investor relations experience in the pharmaceutical industry. During his career, he has successfully managed large global finance functions, implemented transformational projects, and improved operational effectiveness,” said Josef von Rickenbach, Chairman and Chief Executive Officer, PAREXEL. “Simon’s leadership will strengthen our ability to accelerate growth and improve profitability as we implement our corporate strategy.”

Mr. Harford joins PAREXEL from GlaxoSmithKline plc (GSK), where he most recently served as Senior Vice President, Finance, for the company’s Global Pharmaceuticals business based at GSK’s global headquarters in Brentford, England. Prior to joining GSK, Mr. Harford served as Group Vice President and Controller for Avon Products, Inc., in New York. Additionally, he spent two decades with Eli Lilly and Company in various finance leadership roles across Europe and in Indianapolis, most notably as Head of Investor Relations and as Vice President and Controller.

“PAREXEL has a long and distinguished history of providing innovative services to the biopharmaceutical industry, a record that has positioned the Company for long-term growth,” said Mr. Harford. “I look forward to working with PAREXEL’s management team as we leverage growth opportunities and deliver value to our shareholders.”

Mr. Harford, a native of the United Kingdom, holds an MBA from the University of Virginia’s Darden Graduate School of Business.

More information:

Keywords (optional):

parexel, simon-harford, vice-president, chief-financial-officer, appointment,

Company information / Profile:

PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialisation continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 85 locations in 51 countries around the world, and had approximately 19,625 employees in the second quarter. For more information about PAREXEL International visit

PressRelease by


PressContact / Agency:

Erik Kopp
Tel.: +1 781-434-5304
Email: erik.kopp(at)

Jenny Radloff, PAN Communications
Tel: +1 617-502-4300
Email: PAREXEL(at)

published by: RealWire
print pressrelease  send to a friend  

Date: 03/02/2017 - 07:49
Language: English
News-ID 1490135
Character count: 2164
Firma: RealWire
Ansprechpartner: Fran Cator Feedback to about Pressrelease-id:
Stadt: Lincoln
Telefon: 01522 883640

Meldungsart: bitte
Versandart: Veröffentlichung

Number of hits: 390


Direct Link to this PressRelease:

We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease

All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 52

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.